Latest

Morning Rounds

Using Facebook for genomics research & scientists oppose patent law changes

By Shraddha Chakradhar

First Opinion

Quitting smoking is hard. Mindfulness hacks the habit loop, offering a new approach

By Jud Brewer

First Opinion

Cost-cutting jeopardizes many Americans’ access to lifesaving oxygen therapy

By Brian Block and Neeta Thakur

Biotech

‘It felt like an ’80s criminal drama’: What happened when a biohacker met bureaucrats investigating him

By Rebecca Robbins, Adam Feuerstein, and Damian Garde

Health

New evidence points to possible cause of puzzling paralysis in kids

By Maggie Fox

Biotech

Global Blood’s sickle cell disease drug heads to the FDA, but questions about patient benefit still linger

By Adam Feuerstein

Pharmalot

Sanders and Cummings, citing ‘polite f-u letters,’ urge feds to step up probes of generic makers

By Ed Silverman

The Readout LOUD

Listen: Biohacking meets bureaucracy, and the latest twist in CRISPR world

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Biotech

FDA warns of one patient death from a fecal transplant

By Kate Sheridan

Politics

House votes to overturn Trump administration ban on fetal tissue research

By Lev Facher and Megan Thielking

Pharmalot

How a mishap at a photocopier derailed clinical trials and a development deal

By Ed Silverman

In the Lab

Researchers recruit more than 20,000 people for Facebook-based genomics project

By Shraddha Chakradhar

Pharmalot

Pharmalittle: Trump offers to help VA negotiate for J&J drug; Senate panel to mark up drug pricing bill

By Ed Silverman

The Readout

GSK’s CRISPR inroads & panic over China genomics

By Damian Garde

Jennifer Doudna - Genome Editing Conference

Exclusive

GSK partners with CRISPR pioneer Doudna to search for new drugs

By Matthew Herper

Morning Rounds

Trump offers to negotiate esketamine prices & NIH director says no to ‘manels’

By Shraddha Chakradhar

First Opinion

Why I believe the Warren-Cummings CARE Act can stop people like me from becoming opioid overdose statistics

By Ryan Hampton

First Opinion

Ebola vaccine for pregnant women: one step closer but still more to go

By Sonja A. Rasmussen and Denise J. Jamieson

Biotech

Startup Spotlight: Akrevia Therapeutics eyes safer immunotherapies

By Kate Sheridan

Pharmalot

As Amazon seeks to win over health care consumers, its PillPack is accused of violating privacy

By Ed Silverman

Politics

House progressives challenge drug makers to come back to Capitol Hill

By Lev Facher

Pharmalot

Catalyst sues FDA over rivals’ drug approval, warning it undermines incentives for rare disease meds

By Ed Silverman

Politics

Senators want to know if HHS money went to Chinese genomics firms

By Damian Garde

Health

Health officials ramp up Ebola response after first cases reported in Uganda

By Helen Branswell

Pharmalot

Pharmalittle: Florida governor signs importation bill; Oklahoma judge nixes Teva opioid settlement

By Ed Silverman

Facing progressive pressure, Pelosi could expand her drug pricing plan to negotiate prices for $118 billion worth of medicines

Pharmalittle: Bluebird Bio prices gene therapy at $1.8 million; lawmakers urge feds to step up generic probe

Bluebird’s gene therapy for a rare blood disease will cost $1.8 million. Cue the pricing debate

A sickle-cell debate & the legalities of biohacking

Using Facebook for genomics research & scientists oppose patent law changes

Quitting smoking is hard. Mindfulness hacks the habit loop, offering a new approach

Cost-cutting jeopardizes many Americans’ access to lifesaving oxygen therapy

‘It felt like an ’80s criminal drama’: What happened when a biohacker met bureaucrats investigating him

New evidence points to possible cause of puzzling paralysis in kids

Global Blood’s sickle cell disease drug heads to the FDA, but questions about patient benefit still linger

Sanders and Cummings, citing ‘polite f-u letters,’ urge feds to step up probes of generic makers

Listen: Biohacking meets bureaucracy, and the latest twist in CRISPR world

FDA warns of one patient death from a fecal transplant

House votes to overturn Trump administration ban on fetal tissue research

How a mishap at a photocopier derailed clinical trials and a development deal

Researchers recruit more than 20,000 people for Facebook-based genomics project

Pharmalittle: Trump offers to help VA negotiate for J&J drug; Senate panel to mark up drug pricing bill

GSK’s CRISPR inroads & panic over China genomics

GSK partners with CRISPR pioneer Doudna to search for new drugs

Trump offers to negotiate esketamine prices & NIH director says no to ‘manels’

Why I believe the Warren-Cummings CARE Act can stop people like me from becoming opioid overdose statistics

Ebola vaccine for pregnant women: one step closer but still more to go

Startup Spotlight: Akrevia Therapeutics eyes safer immunotherapies

As Amazon seeks to win over health care consumers, its PillPack is accused of violating privacy

House progressives challenge drug makers to come back to Capitol Hill

Catalyst sues FDA over rivals’ drug approval, warning it undermines incentives for rare disease meds

Senators want to know if HHS money went to Chinese genomics firms

Health officials ramp up Ebola response after first cases reported in Uganda

Pharmalittle: Florida governor signs importation bill; Oklahoma judge nixes Teva opioid settlement

Latest

Sign up for our Daily Recap newsletter